Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.3945/ajcn.110.004945. Epub 2010 Nov 10.
Affiliations
- PMID: 21068346
- DOI: 10.3945/ajcn.110.004945
Free article
Randomized Controlled Trial
Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers
Christine Morand et al. Am J Clin Nutr. 2011 Jan.
Free article
Abstract
Background: Although numerous human studies have shown consistent effects of some polyphenol-rich foods on several intermediate markers for cardiovascular diseases, it is still unknown whether their action could be specifically related to polyphenols.
Objective: We investigated the effect of orange juice and its major flavonoid, hesperidin, on microvascular reactivity, blood pressure, and cardiovascular risk biomarkers through both postprandial and chronic intervention studies.
Design: Twenty-four healthy, overweight men (age 50-65 y) were included in a randomized, controlled, crossover study. Throughout the three 4-wk periods, volunteers daily consumed 500 mL orange juice, 500 mL control drink plus hesperidin (CDH), or 500 mL control drink plus placebo (CDP). All measurements and blood collections were performed in overnight-fasted subjects before and after the 4-wk treatment periods. The postprandial study was conducted at the beginning of each experimental period.
Results: Diastolic blood pressure (DBP) was significantly lower after 4 wk consumption of orange juice or CDH than after consumption of CDP (P = 0.02), whereas microvascular endothelium-related reactivity was not significantly affected when measured after an overnight fast. However, both orange juice and CDH ingestion significantly improved postprandial microvascular endothelial reactivity compared with CDP (P < 0.05) when measured at the peak of plasma hesperetin concentration.
Conclusions: In healthy, middle-aged, moderately overweight men, orange juice decreases DBP when regularly consumed and postprandially increases endothelium-dependent microvascular reactivity. Our study suggests that hesperidin could be causally linked to the beneficial effect of orange juice. This trial is registered at clinicaltrials.gov as NCT00983086.
Similar articles
- Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study.
Milenkovic D, Deval C, Dubray C, Mazur A, Morand C. Milenkovic D, et al. PLoS One. 2011;6(11):e26669. doi: 10.1371/journal.pone.0026669. Epub 2011 Nov 16. PLoS One. 2011. PMID: 22110589 Free PMC article. Clinical Trial. - Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease.
Schär MY, Curtis PJ, Hazim S, Ostertag LM, Kay CD, Potter JF, Cassidy A. Schär MY, et al. Am J Clin Nutr. 2015 May;101(5):931-8. doi: 10.3945/ajcn.114.104364. Epub 2015 Mar 18. Am J Clin Nutr. 2015. PMID: 25788001 Free PMC article. Clinical Trial. - Orange juice and its major polyphenol hesperidin consumption do not induce immunomodulation in healthy well-nourished humans.
Perche O, Vergnaud-Gauduchon J, Morand C, Dubray C, Mazur A, Vasson MP. Perche O, et al. Clin Nutr. 2014 Feb;33(1):130-5. doi: 10.1016/j.clnu.2013.03.012. Epub 2013 Mar 26. Clin Nutr. 2014. PMID: 23602614 Clinical Trial. - Impact of hesperidin in 100% orange juice on chronic disease biomarkers: A narrative systematic review and gap analysis.
Tadros FJ, Andrade JM. Tadros FJ, et al. Crit Rev Food Sci Nutr. 2022;62(30):8335-8354. doi: 10.1080/10408398.2021.1927976. Epub 2021 May 20. Crit Rev Food Sci Nutr. 2022. PMID: 34014143 - Hesperidin, a major flavonoid in orange juice, might not affect lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials.
Mohammadi M, Ramezani-Jolfaie N, Lorzadeh E, Khoshbakht Y, Salehi-Abargouei A. Mohammadi M, et al. Phytother Res. 2019 Mar;33(3):534-545. doi: 10.1002/ptr.6264. Epub 2019 Jan 10. Phytother Res. 2019. PMID: 30632207
Cited by
- Optimization of a polyphenol extraction method for sweet orange pulp (Citrus sinensis L.) to identify phenolic compounds consumed from sweet oranges.
Iglesias-Carres L, Mas-Capdevila A, Bravo FI, Aragonès G, Muguerza B, Arola-Arnal A. Iglesias-Carres L, et al. PLoS One. 2019 Jan 30;14(1):e0211267. doi: 10.1371/journal.pone.0211267. eCollection 2019. PLoS One. 2019. PMID: 30699169 Free PMC article. - Anti-hypertensive effect of crocin and hesperidin combination in high-fat diet treated rats.
Hashemzaei M, Rezaee R, Nabatzehi M, Tsarouhas K, Konstantinos Nikolouzakis T, Lazopoulos G, A Spandidos D, Tsatsakis A, Shahraki J. Hashemzaei M, et al. Exp Ther Med. 2020 Jun;19(6):3840-3844. doi: 10.3892/etm.2020.8650. Epub 2020 Apr 8. Exp Ther Med. 2020. PMID: 32346448 Free PMC article. - Endothelium and its alterations in cardiovascular diseases: life style intervention.
Favero G, Paganelli C, Buffoli B, Rodella LF, Rezzani R. Favero G, et al. Biomed Res Int. 2014;2014:801896. doi: 10.1155/2014/801896. Epub 2014 Feb 26. Biomed Res Int. 2014. PMID: 24719887 Free PMC article. Review. - Interindividual Variability in Biomarkers of Cardiometabolic Health after Consumption of Major Plant-Food Bioactive Compounds and the Determinants Involved.
Milenkovic D, Morand C, Cassidy A, Konic-Ristic A, Tomás-Barberán F, Ordovas JM, Kroon P, De Caterina R, Rodriguez-Mateos A. Milenkovic D, et al. Adv Nutr. 2017 Jul 14;8(4):558-570. doi: 10.3945/an.116.013623. Print 2017 Jul. Adv Nutr. 2017. PMID: 28710143 Free PMC article. Review. - Combination therapy of flaxseed and hesperidin enhances the effectiveness of lifestyle modification in cardiovascular risk control in prediabetes: a randomized controlled trial.
Yari Z, Naser-Nakhaee Z, Karimi-Shahrbabak E, Cheraghpour M, Hedayati M, Mohaghegh SM, Ommi S, Hekmatdoost A. Yari Z, et al. Diabetol Metab Syndr. 2021 Jan 6;13(1):3. doi: 10.1186/s13098-020-00619-y. Diabetol Metab Syndr. 2021. PMID: 33402222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources